| Literature DB >> 36038848 |
Susmita Chatterjee1,2,3, Palash Das4, Anna Vassall5.
Abstract
BACKGROUND: The nationwide lockdown (March 25 to June 8, 2020) to curb the spread of coronavirus infection had significant health and economic impacts on the Indian economy. There is limited empirical evidence on how COVID-19 restrictive measures may impact the economic welfare of specific groups of patients, e.g., tuberculosis patients. We provide the first such evidence for India.Entities:
Keywords: COVID-19; Economic impact; Employment; Financial Impact; Income loss; India; Informal sector; Tuberculosis
Mesh:
Substances:
Year: 2022 PMID: 36038848 PMCID: PMC9421110 DOI: 10.1186/s12879-022-07681-z
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.667
Number of TB patients included in the study
| Continuation phase interviews (Timeline: July–August 2020) | ||
|---|---|---|
| General population | Tea garden families | |
| Number of TB patients interviewed | 89 | 202 |
|
| ||
| Household income loss during complete lockdown (April-May 2020) and from April 2020 till the date of interview in July-August 2020 | 89 | 202 |
|
| ||
| Drug pick-up pattern from March 25, 2020, till the end of TB treatment and same number of days before lockdown | 72 | 146 |
| Medicine discontinuation (if any) from March 25, 2020, till the end of TB treatment | 88 | 202 |
|
| ||
| Number of TB patients interviewed | 101 | 240 |
|
| ||
| Household income loss from April 2020 till the date of interview in January-February 2021 | 84 | 193 |
(1) Number of TB patients interviewed in post treatment period (101) is higher than patients interviewed in continuation phase (89) because of loss to follow up in continuation phase but followed up in post treatment period. As continuation phase interviews was over phone, there were loss to follow up because of non-availability through phone. (2) Difference in number of TB patients interviewed for household income loss from April 2020 till January - February 2021 (84) as compared to patients interviewed in post treatment follow-up (101) is because of availability of household income data for both continuation phase and post treatment interviews. (3) Number of patients covered under drug pick-up are less than the number covered in continuous phase interview as some were under daily directly observed treatment (DOT) and pickup was not applicable. (4) Sample size for medicine discontinuation of general population is less as one patient defaulted and stopped medicine before lockdown started
Reasons of loss to follow up
| Intensive phase – N (January-February 2020) | Continuation phase – N (July-August 2020) | Reasons – N (%) | |
|---|---|---|---|
| General population | 121 | 89 | Death – 5 (4.13%) Refusal – 6 (4.96%) No trace – 4 (3.30%) Could not be contacted over phone – 17 (14.05%) Total – 32 (26.45%) |
| Tea garden families | 279 | 202 | Death – 20 (7.17%) Shifted to MDR – 4 (1.43%) No trace – 4 (1.43%) Migrate out – 1 (0.36%) Cancelled because of misdiagnosis – 1 (0.36%) Could not be contacted over phone – 47 (16.85%) Total – 77 (27.60%) |
MDR multidrug resistant TB
Characteristics of study participants
| Continuation phase (July–August 2020) | ||
|---|---|---|
| General population (N = 89) | Tea garden families (N = 202) | |
|
| ||
| 18–24 years | 21 (23.60) | 53 (26.24) |
| 25–34 years | 23 (25.84) | 54 (26.73) |
| 35–44 years | 22 (24.72) | 52 (25.74) |
| 45–54 years | 14 (15.73) | 23 (11.39) |
| 55–64 years | 6 (6.74) | 17 (8.42) |
| 65 years and above | 3 (3.37) | 3 (1.49) |
|
| ||
| Male | 64 (71.91) | 114 (56.44) |
| Female | 25 (28.09) | 88 (43.56) |
|
| ||
| Not attended school | 15 (16.85) | 94 (46.53) |
| Primary | 41 (46.07) | 86 (42.57) |
| Secondary | 12 (13.48) | 13 (6.44) |
| Higher secondary | 11 (12.36) | 6 (2.97) |
| Graduate | 10 (11.24) | 3 (1.49) |
| Post-graduate and above | 0 (0.00) | 0 (0.00) |
|
| ||
| Unemployed | 7 (7.87) | 15 (7.43) |
| Formal paid work | 12 (13.48) | 72 (35.64) |
| Informal paid work | 33 (37.08) | 69 (34.16) |
| Retired | 2 (2.25) | 3 (1.49) |
| Student | 5 (5.62) | 9 (4.46) |
| Homemaker | 12 (13.48) | 25 (12.38) |
| Self-occupied | 18 (20.22) | 9 (4.46) |
|
| ||
| Pulmonary, bacteriologically confirmed | 39 (43.82) | 104 (51.49) |
| Pulmonary, bacteriologically unconfirmed | 14 (15.73) | 43 (21.29) |
| Extra pulmonary | 36 (40.45) | 55 (27.23) |
Figures in parentheses indicate percentage
Fig. 1Percentage of households in different income groups over time: average monthly household income in 2020 US$ (patients in general population interviewed during July–August 2020, during continuation phase of treatment, N = 89)
Fig. 2Percentage of households in different income groups over time: average monthly household income in 2020 US$ (patients in tea garden families interviewed during July–August 2020, during continuation phase of treatment, N = 202)
Average monthly household income and income loss at different time points (2020 US$)
| Number | Average monthly income before lockdown (February 2020) - US$, 95% CI (LB, UB) | Average monthly income during lockdown (April-May 2020) - US$, 95% CI (LB, UB) | Average monthly income at the time of interview (July-August 2020) - US$, 95% CI (LB, UB) | Average per household income loss during April- May 2020 - US$, 95% CI (LB, UB) | Average per household income loss from April-August 2020 - US$, 95% CI (LB, UB) | |
|---|---|---|---|---|---|---|
| General population | 89 | 202.59 (159.73, 245.46) | 114.44 (72.81, 156.07) | 161.73 (118.83, 204.63) | (−) 220.39 (− 273.14, − 167.63) | (−) 153.96 (− 228.37, − 79.55) |
| Tea garden families | 202 | 85.95 (75.97, 95.93) | 47.21 (39.89, 54.53) | 88.20 (78.99, 97.42) | (−) 96.85 (− 118.43, − 75.28) | 11.70 (− 16.37, 39.77) |
CI, confidence interval; LB, lower bound; UB, upper bound